July 21, 2017 at 5pm PST. When will the finalists be notified? August 21, 2017 at 5pm PST. Will TechCrunch’s team help prepare startups for the pitch-off sigelei fuchai 200w? Yes; in-person training and rehearsal sessions will be required, as well in-person rehearsal on October 10. What else do I need to know Accountancy BBA? The pitch-off is on October 11, 2017 . There will be a reception at the end of the pitch-off, where each company will have room to exhibit and talk 1:1 with pitch-off attendees. What countries are eligible? Residents in the following countries may apply: Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cabo Verde, Central Africa Republic, Chad, Comoros, Republic of the Congo, Democratic Republic of the Congo, Cote d’Ivoire, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Sao Tome and Principe, Senegal , Seychelles, Sierra Leone, Somalia, South Africa, South Sudan, Swaziland, Tanzania, Togo, Uganda, Zambia and Zimbabwe. Notwithstanding anything to the contrary in the foregoing language, the “Applicable Countries” does not include any country to or on which the United States has embargoed goods or imposed targeted sanctions (including, but not limited to, Sudan). — did your brain just explode Virtual Desktop? In a new study published in Nature, a group of scientists at Harvard have successfully stored a GIF— yes, like a moving meme — into live bacteria (E. coli to be specific). It’s a weird idea, but scientists have actually been using the genetic wondertool known as CRISPR or “clustered regularly interspaced short palindromic repeats” for data storage parlor tricks for some time. CRISPR, explained in a bit more depth here, makes all sorts of wild things possible and people are rightfully excited about it. Those revelations are often reserved for geneticists and health researchers, but the Harvard experiment and others like it demonstrate CRISPR’s utility even beyond its vas, untapped potential in the world of medicine.